Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Accurate coagulation testing starts with proper specimen preparation. Even small pre-analytic errors, such as underfilled tubes, hemolysis, or improper centrifugation, can compromise results and patient care.
This week's research roundup features: Transcriptomic analysis of cirrhosis-like hepatocellular carcinoma reveals distinct molecular characteristics and pathologic staging implications
Topic highlights include: New Mayo Clinic scanner is first of its kind in North America, Mayo Clinic Health System allergist shares advice for finding relief this allergy season, Vaccine appears to protect against monkeypox, CDC says
New research led by the Lunenfeld-Tannenbaum Research Institute, Mount Sinai Hospital, Toronto; Mayo Clinic Comprehensive Cancer Center; and Mayo Clinic Center for Individualized Medicine has identified the biologic mechanism of a germline alteration that may be critical for developing new therapies to treat and prevent a type of brain tumor.
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Matt Binnicker, Ph.D., director of Clinical Virology and vice chair of practice in the Department of Laboratory Medicine and Pathology at Mayo Clinic, to discuss the laboratory medicine perspective of Monkeypox.
In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the stabilization of monkeypox and COVID-19, the shift from pandemic to endemic status, the increase in global virus outbreaks, and the role that laboratory medicine plays in this changing health environment.
Deb Wells is the director of Quality Management Services at Mayo Clinic Laboratories. A science lover from a young age, Deb has long worked in medical laboratory science and is passionate about being an advocate for lab safety and quality.
This week's research roundup features: Tumor microenvironment CD14+ cells correlate with poor overall survival in patients with early-stage lung adenocarcinoma
Two years ago, when 29-year-old Meckenzie Tinaglia experienced a series of seizure-like events shortly after a cardiac ablation procedure, she knew her heart was to blame. Her local providers, however, weren’t convinced. If not for Mayo Clinic remote cardiac monitoring and the data it provided about Meckenzie’s potentially fatal arrythmia, the busy wife and young mother might not have survived.
This list includes updates posted to mayocliniclabs.com during the month of September.
Topic highlights include: Mayo Clinic Health System turns 30, Doctors say now is time to get flu shot, White House releases strategy for ending hunger in US by 2030
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice cover current trends for monkeypox and COVID-19, their thoughts as autumn begins, getting back to infection prevention basics, and a quick legislation update.